12:00 AM
 | 
Jun 12, 2006
 |  BC Week In Review  |  Company News  |  Deals

A&G, Celltrion deal

Celltrion will manufacture preclinical and clinical batches of A&G's anti-GP88 monoclonal antibody, which is in preclinical development for cancer....

Read the full 75 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >